Login to Your Account

Tissue Regenix Brings in $39M To Advance dCell Technology

By Nuala Moran
BioWorld International Correspondent

Wednesday, December 14, 2011
LONDON – Closing the year with some cheer for the sector, Tissue Regenix Group plc has raised £25 million (US$39 million) in a placing, enabling the regenerative medicine specialist to begin to advance several programs in parallel.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription